News & Updates
Filter by Specialty:
Longer time in BP target protects against adverse cardiovascular events in diabetes
For patients with hypertension and diabetes, longer time spent in blood pressure (BP) target range helps lower the risk of cardiovascular disease, according to a study.
Longer time in BP target protects against adverse cardiovascular events in diabetes
08 Mar 2023GLP-1 RAs vs SGLT2 inhibitors: What are the comparative risks of ischaemic stroke and incident AF?
A population-based retrospective study of Hong Kong patients with type 2 diabetes (T2D) finds that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a lower risk of ischaemic stroke, while use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is associated with a lower risk of atrial fibrillation (AF).
GLP-1 RAs vs SGLT2 inhibitors: What are the comparative risks of ischaemic stroke and incident AF?
08 Mar 2023Metformin plus oral contraceptives an alternative treatment for nonobese women with PCOS
In the treatment of polycystic ovary syndrome (PCOS), the combination of metformin plus oral contraceptives appears to benefit women without obesity, inducing favourable effects on glucose metabolism with no further harm on lipid metabolism, according to the results of a meta-analysis.
Metformin plus oral contraceptives an alternative treatment for nonobese women with PCOS
07 Mar 2023Insulin resistance, fertility outcomes favour carnitine in PCOS
Carnitine appears to be beneficial in the treatment of women with polycystic ovary syndrome (PCOS), with the drug helping improve ovulation, clinical pregnancy, insulin resistance, and body mass index, according to the results of a meta-analysis.
Insulin resistance, fertility outcomes favour carnitine in PCOS
05 Mar 2023SGLT-2I–MRA combo yields maximal kidney, cardiovascular protection in T2DM, CKD
Sodium-glucose cotransporter-2 inhibitors (SGLT-2Is) confer the greatest reduction in kidney and cardiovascular risks in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), according to a study.
SGLT-2I–MRA combo yields maximal kidney, cardiovascular protection in T2DM, CKD
05 Mar 2023Obesity, metabolic dysfunction linked to BPE in premenopausal women
A recent study has established the association of increased background parenchymal enhancement (BPE) with obesity, insulin resistance, leptin, and adiponectin in premenopausal women who are at high risk of breast cancer.
Obesity, metabolic dysfunction linked to BPE in premenopausal women
28 Feb 2023Diet, physical activity help lower cardiometabolic disease risk
Behavioural weight-loss interventions, such as diet alone and diet plus physical activity (PA), induce a beneficial change in biomarkers of insulin resistance and cardiometabolic health in adults with overweight or obesity, reports a study. However, no additional benefit has been observed with the addition of moderate-intensity PA to a diet-only intervention.